This page shows the latest MedImmune news and features for those working in and with pharma, biotech and healthcare.
Viela Bio spun out of AstraZeneca’s Medimmune biologics unit in 2018 with six molecules and $250m in funding from a number of investors.
Funds will help to push a number of pipeline candidates. Almost two years after spinning out of AstraZeneca’s Medimmune biologics unit, Viela Bio has filed for an initial public offering
Will also drop other candidates that haven’t hit the mark. The demise of the MedImmune brand, which has driven AstraZeneca’s biologics pipeline for more than a decade, will strengthen ... And in particular, whether its entrepreneurial culture could
Chief commercial officer Mark Mallon has taken on the CEO role at US biotech Ironwood Pharmaceuticals, while Medimmune research head Bahija Jallal agreed to take the helm of UK biotech company
her post as research head of AZ’s biotech arm MedImmune to head up UK biotech company Immunocore. ... Mene Pangalos will be the leader of a new unified Research and Development unit for BioPharmaceuticals, ending the split between MedImmune biologics
NGF inhibitors have had a chequered history, with a long list of discontinued candidates, mainly due to side effect issues, from the likes of AstraZeneca/Medimmune and AbbVie, amongst others.
More from news
Approximately 12 fully matching, plus 88 partially matching documents found.
Imfinzi, competing in the hypercompetitive world of immuno-oncology, was developed by MedImmune, the company’s US-based biologics research division, while the two small molecule drugs were developed in the ... The third area is immuno-oncology (IO)
This physical environment gives us an opportunity to work in a different way,” said Jane Osbourn, the company’s site lead and vice-president for research and development at MedImmune, its
Sanofi, MedImmune, AstraZeneca, Astellas, Novartis and more feature in this month's pharma deals round-up. ... Headline. $m. AstraZeneca/ MedImmune. Sanofi Pasteur. Joint Development. MEDI8897; monoclonal antibody to respiratory syncytial virus in phase
Licensee / Acquirer. Deal type. Product /technology. Headline $m. Medimmune / AstraZeneca (UK).
We have seen this for several of the large pharma firms and this month AstraZeneca licensed an antibody developed by MedImmune to start-up company Corvidia Therapeutics concurrently with Corvidia's ... acquisition - corporate. 29.35. AstraZeneca/
More from intelligence
Approximately 1 fully matching, plus 13 partially matching documents found.
Before Immunocore Berman most recently served as senior vice president and head of the AstraZeneca Immuno-oncology franchise, where he was responsible for early stage oncology programme MedImmune.
Bahija has more than 25 years of international leadership experience within the pharmaceutical industry, and joins Immunocore from AstraZeneca, where she has served as President of MedImmune, its global biologics research ... Since joining MedImmune in
Dr Jean-Charles Soria and Dr Geoffrey Kim join the company. AstraZeneca and its global biologics research and development arm MedImmune, has appointed Dr Geoffrey Kim and Dr Jean-Charles Soria, ... Soria also taking up a leadership role within AZ’s
Dr Jamie Freedman joins from AZ subsidiary MedImmune. AstraZeneca has appointed Dr Jamie Freedman as its new head of oncology, succeeding Dr Mondher Mahjoubi. ... Dr Freedman moves to AstraZeneca from its subsidiary MedImmune, where he was senior vice
He has also served as vice president and head of clinical development oncology at MannKind, and held clinical leadership positions at MedImmune and Sigma-Tau Research.
More from appointments
Approximately 5 fully matching, plus 12 partially matching documents found.
Having completed her Masters in Biotechnology from one of France’s most prestigious universities, Cécile has previously worked in laboratory settings and clinical trials with Re:Cognition Health and MedImmune, part
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...